Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial

NCT00010452 is registered in ClinicalTrials.gov with University of Iowa as lead sponsor.

NCT NCT00010452
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00010452 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Cystic Hygroma (Lymphangiomas) in Children- Picibanil(OK432) Sclerotherapy-Multicenter Trial
Lead sponsor
University of Iowa
Phase
Phase 2/3
Overall status
Completed
Start date
April 30, 2000
Completion date
November 30, 2007
Enrollment
150 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic malformations